Abstract
Epstein–Barr virus (EBV) remains latent in 90% of the patients following primary infection. The infection might be reactivated due to various stress factors. We, therefore, examined the levels of stress hormones (epinephrine, norepinephrine and cortisol), viral capsid antigen (VCA) immunoglobulin Ig G, VCA IgM, EBV early antigen IgG, Epstein–Barr nuclear antigen (EBNA) IgG, EBNA IgM antibody screening tests and performed EBV polymerized chain reaction (PCR) test and EBV DNA PCR in 100 draftees on their first day of recruitment and at the end of 1 month. Examination of the initial samples revealed that 94 (94%) subjects previously had EBV infection and 6 (6%) were seronegative. Second samples obtained at the end of first month showed that 7 (7.4%) reactivations occurred in 94 subjects who previously had EBV infection (P < 0.001). Two out of six (33.3%) who were initially seronegative had acute infection (P = 0.289). There was no significant difference between the median values of the levels of stress hormones in the initial and second serum and plasma samples. There was a significant difference between the rates of acute infection and reactivation among subjects with elevated cortisol and epinephrine levels in the second samples compared to subjects with normal levels (P < 0.001). No significant difference was determined between the first and second sample hormone levels of all nine subjects whose EBV-DNA turned positive. Routine examinations might not reveal any specific findings since EBV infection often has an asymptomatic course. EBV reactivations should always be kept in mind in patients subject to such stressful conditions.
Similar content being viewed by others
References
Sarid O, Anson O, Yaari A, Margalith M (2001) Epstein-Barr virus specific salivary antibodies as related to stress caused by examinations. J Med Virol 64(2):149–156
Kiecolt-Glaser JK, Glaser R (1988) Methodological issues in behavioral immunology research with humans. Brain Behav Immun 2(1):67–78
Segerstrom SC, Miller GE (2004) Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull 130(4):601–630
Maier SF, Watkins LR (1998) Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 105(1):83–107
Jones JF, Shurin S, Abramowsky C, Tubbs RR, Sciotto CG, Wahl R et al (1988) T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 318(12):733–741
Stowe RP, Pierson DL, Feeback DL, Barrett AD (2000) Stress-induced reactivation of Epstein-Barr virus in astronauts. Neuroimmunomodulation 8(2):51–58
Fung MK, Mordarski KT, Bader SA, Gronowski AM (2002) Evaluation of the Wampole Laboratories ELISA-based assay for Epstein-Barr virus serology. Clin Chim Acta 319(1):43–48
Linde A, Falk K (2007) Epstein-Barr virus. In: Murray PR, Boron EJ, Jorgensen JH, Landry ML, Pfaller MA (eds) Manual of clinical microbiology. ASM press, Washington DC, pp 1564–1573
Johannsen EC, Schooley RT, Kaye KM (2005) Ebstein-Barr Virus (infectious mononucleosis). In: Mandell GL, Bennett JE, Dolin R (eds) Mandel, Dougles and Bennett’s principles and practise of infectious disease, 6th edn. Elsevier churchill livingstone, Philadelphia, pp 1801–1820
Sambrook J, Fritsch EF, Maniatis T (1989) Appendices B16. Molecular cloning, 2nd edn. Cold Spring Harbor Laboratory Press, New York
Yapar M, Aydogan H, Pahsa A, Besirbellioglu BA, Bodur H, Basustaoglu AC et al (2005) Rapid and quantitative detection of Crimean-Congo hemorrhagic fever virus by one-step real-time reverse transcriptase-PCR. Jpn J Infect Dis 58(6):358–362
Kubar A, Saygun I, Ozdemir A, Yapar M, Slots J (2005) Real-time polymerase chain reaction quantification of human cytomegalovirus and Epstein-Barr virus in periodontal pockets and the adjacent gingiva of periodontitis lesions. J Periodontal Res 40(2):97–104
Hess RD (2004) Routine Epstein-Barr Virus diagnostics the laboratory perspective: still challenging after 35 years. J Clin Microbiol 42:3381–3387
Gartner BC, Hess RD, Bandt D, Kruse A, Rethwilm A, Roemer K et al (2003) Evaluation of four commercially available Epstein-Barr virus enzyme immunoassays with an immunofluorescence assay as the reference method. Clin Diagn Lab Immunol 10(1):78–82
Aydemir Ş, Erensoy S, Zeytinoğlu A, Bilgiç A (1998) Epstein-Barr virus seroprevalenceı: a field study, 18th microbiology congress. Turcish microbiology association, Antalya Turkey
Fidan I, Yüksel S, Imir T (2005) The investigation of EBV antibodies in different age groups. Turk J Infect 19(4):453–456
Yenen OS, Mete Z (1988) A study on spesific serology of EBV. İnfeksiyon derg 2(2):233
Glaser R, Padgett DA, Litsky ML, Baiocchi RA, Yang EV, Chen M et al (2005) Stress-associated changes in the steady-state expression of latent Epstein-Barr virus: implications for chronic fatigue syndrome and cancer. Brain Behav Immun 19(2):91–103
Glaser R, Pearson GR, Jones JF, Hillhouse J, Kennedy S, Mao HY et al (1991) Stress-related activation of Epstein-Barr virus. Brain Behav Immun 5(2):219–232
Glaser R, Kiecolt-Glaser JK, Bonneau RH, Malarkey W, Kennedy S, Hughes J (1992) Stress-induced modulation of the immune response to recombinant hepatitis B vaccine. Psychosom Med 54(1):22–29
Gmunder FK, Konstantinova I, Cogoli A, Lesnyak A, Bogomolov W, Grachov AW (1994) Cellular immunity in cosmonauts during long duration spaceflight on board the orbital MIR station. Aviat Space Environ Med 65(5):419–423
Taylor GR, Janney RP (1992) In vivo testing confirms a blunting of the human cell-mediated immune mechanism during space flight. J Leukoc Biol 51(2):129–132
Taylor GR, Konstantinova I, Sonnenfeld G, Jennings R (1997) Changes in the immune system during and after spaceflight. Adv Space Biol Med 6:1–32
Taylor GR, Neale LS, Dardano JR (1986) Immunological analyses of U.S. space shuttle crewmembers. Aviat Space Environ Med 57(3):213–217
Bauer CC, Aberle SW, Popow-Kraupp T, Kapitan M, Hofmann H, Puchhammer-Stockl E (2005) Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection. J Med Virol 75(1):54–58
Fafi-Kremer S, Morand P, Brion JP, Pavese P, Baccard M, Germi R et al (2005) Long-term shedding of infectious Epstein-Barr virus after infectious mononucleosis. J Infect Dis 191(6):985–989
Papesch M, Watkins R (2001) Epstein-Barr virus infectious mononucleosis. Clin Otolaryngol Allied Sci 26(1):3–8
Stowe RP, Pierson DL, Barrett AD (2001) Elevated stress hormone levels relate to Epstein-Barr virus reactivation in astronauts. Psychosom Med 63(6):891–895
Miller GE, Cohen S, Ritchey AK (2002) Chronic psychological stress and the regulation of pro-inflammatory cytokines: a glucocorticoid-resistance model. Health Psychol 21(6):531–541
Cacioppo JT, Kiecolt-Glaser JK, Malarkey WB, Laskowski BF, Rozlog LA, Poehlmann KM et al (2002) Autonomic and glucocorticoid associations with the steady-state expression of latent Epstein-Barr virus. Horm Behav 42(1):32–41
Conflict of interest statement
The authors declare that they have no conflict of interest related to the publication of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Coskun, O., Sener, K., Kilic, S. et al. Stress-related Epstein–Barr virus reactivation. Clin Exp Med 10, 15–20 (2010). https://doi.org/10.1007/s10238-009-0063-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10238-009-0063-z